Calistoga Pharmaceuticals was founded
In 2006, Calistoga Pharmaceuticals was founded as a Seattle-based spin-off from ICOS Corp. that was dedicated to developing…
In 2006, Calistoga Pharmaceuticals was founded as a Seattle-based spin-off from ICOS Corp. that was dedicated to developing…
On Jul. 12, 2005, Corixa Corp., based on First Hill in Seattle, was acquired by Glaxosmithkline (GSK) for…
On Feb. 15, 2005, in response to concerns about the safety of a number of prescription medicines, the…
On Aug. 24, 2004, Eli Lilly and Company launched Cymbalta (duloxetine HC), a new treatment for major depression…
On May 20, 2004, the Medicare Prescription Drug Improvement and Modernization Act, signed in 2003, required among other…
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
In 2004, the Siteman Cancer Center established a Good Manufacturing Practice (GMP) facility, the first built in partnership…
On Nov. 21, 2003, Cialis (tadalafil), discovered through a Glaxo Wellcome and ICOS Corp. partnership, was first approved…
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
On Nov. 12, 2002, Cialis, a medication to treat male erectile dysfunction, manufactured by Eli Lilly and Company,…
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
On Jan. 12, 2001, Corus Pharma was incorporated as a private venture-backed development stage biopharmaceutical company focused on…
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
On Jul. 29, 1999, Gilead Sciences and NeXstar Pharmaceuticals announced the closing of their agreement whereby Gilead acquired…
On Apr. 15, 1999, the Tennessee Biotechnology Association (TBA), now the Life Science Tennessee, was established. The Tennessee…
On Mar. 27, 1999, Novo Nordisk, the ZymoGenetics parent company, announced approval of NovoSeven by the Food and…
On Feb. 7, 1999, National Black HIV/AIDS Awareness Day was founded by five national organizations funded by the…
On Jan. 17, 1999, Jane E. Henney, M.D., appointed by President Bill Clinton, became the first woman to…
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
In 1998, LigoCyte Pharmaceuticals was founded in Bozeman by Robert F. Bargatze, Ph.D., and John W. Jutila, Ph.D….
On Aug. 9, 1997, the U.S. Food and Drug Administration (FDA) announced a policy that allowed pharmaceutical companies…
In 1997, Bristol-Myers Squibb opened a 433-acre research campus in Hopewell, New Jersey. Two important new medicines co-developed…
In 1996, Texas Healthcare & Bioscience Institute (THBI) was founded in Austin. The mission of the Texas Healthcare…
On Sept. 27, 1995, a series of proposed reforms to reduce regulatory burden on pharmaceutical manufacturers were announced….
In 1995, Bristol-Myers’ Wallingford, Connecticut facility was named the Richard L. Gelb Center for Pharmaceutical Research and Development…
On May 13, 1992, the U.S. Congress announced the Generic Drug Enforcement Act, sponsored by Rep. John Dingell…
In 1990, BayBio, a non-profit 501(c)(3) organization headquartered in San Francisco, was founded by a consortium of universities,…